CA2137367A1 - Peptides agissant comme des facteurs de croissance derives des plaquettes - Google Patents

Peptides agissant comme des facteurs de croissance derives des plaquettes

Info

Publication number
CA2137367A1
CA2137367A1 CA002137367A CA2137367A CA2137367A1 CA 2137367 A1 CA2137367 A1 CA 2137367A1 CA 002137367 A CA002137367 A CA 002137367A CA 2137367 A CA2137367 A CA 2137367A CA 2137367 A1 CA2137367 A1 CA 2137367A1
Authority
CA
Canada
Prior art keywords
seq
peptide
pdgf
peptides
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002137367A
Other languages
English (en)
Inventor
Amrit K. Judd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SRI International Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2137367A1 publication Critical patent/CA2137367A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002137367A 1992-06-05 1993-06-03 Peptides agissant comme des facteurs de croissance derives des plaquettes Abandoned CA2137367A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89449792A 1992-06-05 1992-06-05
US07/894,497 1992-06-05

Publications (1)

Publication Number Publication Date
CA2137367A1 true CA2137367A1 (fr) 1993-12-23

Family

ID=25403155

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002137367A Abandoned CA2137367A1 (fr) 1992-06-05 1993-06-03 Peptides agissant comme des facteurs de croissance derives des plaquettes

Country Status (3)

Country Link
JP (1) JPH07508510A (fr)
CA (1) CA2137367A1 (fr)
WO (1) WO1993025576A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU701576B2 (en) * 1993-10-22 1999-02-04 Trigen Limited Platelet-derived growth factor analogues
US5952304A (en) 1993-10-22 1999-09-14 Trigen Limited Platelet-derived growth factor analogues
KR20130100383A (ko) * 2009-04-13 2013-09-10 이엘씨 매니지먼트 엘엘씨 메티오닌 술폭시드 펩티드, 조성물 및 사용 방법
EP3013851A4 (fr) * 2013-06-25 2016-12-28 Sépia Pesquisa E Desenvolvimento Modulateurs des récepteurs de la bradykinine et leur utilisation
PL240667B1 (pl) * 2018-03-26 2022-05-16 Gdanski Univ Medyczny Peptyd, będący fragmentem płytkopochodnego czynnika wzrostu do zastosowania jako środek leczniczy do podania na skórę w zaburzeniach naskórka do stymulacji odbudowy naskórka

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751632T2 (de) * 1986-08-13 1996-06-13 Zymogenetics Inc Expression von biologisch-aktiven PDGF-Analogen in eukaryotischen Zellen
WO1992011364A1 (fr) * 1990-12-21 1992-07-09 Creative Biomolecules, Inc. Antagonistes biosynthetiques de facteur de croissance plaquettaire

Also Published As

Publication number Publication date
WO1993025576A3 (fr) 1994-04-14
JPH07508510A (ja) 1995-09-21
WO1993025576A2 (fr) 1993-12-23

Similar Documents

Publication Publication Date Title
AU565347B2 (en) Repair of tissue in animals
US4493795A (en) Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US5200397A (en) Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
US4816561A (en) Biologically active polypeptides
US4190646A (en) Polypeptide compositions and methods
US5240912A (en) Transforming growth factor (TGF) peptides
US5656587A (en) Promotion of cell proliferation by use of transforming growth factor beta (TGF-β)
US4863899A (en) Biologically active polypeptides
FI104253B (fi) Menetelmä terapeuttisesti käyttökelpoisten nonapeptidibombesiiniantagonistien valmistamiseksi
JPH03504013A (ja) Ｔ細胞ヘルパー活性を有するペプチド
EP0166612A2 (fr) Analogues de thymopentine active
US4859765A (en) Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4002740A (en) Tridecapeptide compositions and methods
WO1988008852A1 (fr) Peptides synthetiques pour le diagnostic et la prevention d'infections par le virus influenza, et leur utilisation
CA1141375A (fr) Tripeptides et methodes
CA2157506C (fr) Oligopeptides de croissance pour l'osteogenese; compositions pharmaceutiques a base de ces produits
US6339062B1 (en) Retroinverso polypeptides that mimic or inhibit thrombospondin activity
CA2137367A1 (fr) Peptides agissant comme des facteurs de croissance derives des plaquettes
US5840692A (en) Peptide fragments and analogs of thrombospondin
EP0310887B1 (fr) Peptide vaso-constricteur
US5087562A (en) Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US6239110B1 (en) Synthetic analogs of thrombospondin and therapeutic use thereof
US5648461A (en) Synthetic analogs of thrombospondin and therapeutic use thereof
EP0364481A1 (fr) Facteurs de croissance
US4258151A (en) Pentapeptide modified resin

Legal Events

Date Code Title Description
FZDE Dead